Abstract
Purpose
To test whether longitudinally measured health-related quality of life (HRQL) predicts transplant-related mortality (TRM) in pediatric hematopoietic stem cell transplant (HSCT).
Methods
The predictors of interest were emotional functioning, physical functioning, role functioning, and global HRQL, as rated by the parent about the child up to 6 times over 12 months of follow-up and measured by the Child Health Ratings Inventories. We used joint models, specifically shared parameter models, with time to TRM as the outcome of interest and other causes of mortality as a competing risk, via the JM software package in R. Choosing shared parameter models instead of standard survival models, such as Cox models with time-dependent covariates, enabled us to address measurement error in the HRQL trajectories and appropriately handle missing data. The nonlinear trajectories for each HRQL domain were modeled by random spline functions. The survival submodels were adjusted for baseline patient, family, and transplant characteristics.
Results
Hazard ratios per one-half standard deviation difference in emotional, physical, and role functioning, and global HRQL were 0.61 (95 % CI 0.46–0.81; p < 0.001), 0.70 (0.51–0.96; p = 0.03), 0.54 (0.34–0.85; p = 0.007), and 0.57 (0.41–0.79; p < 0.001), respectively.
Conclusions
HRQL trajectories were predictive of TRM in pediatric HSCT, even after adjusting the survival outcome for baseline characteristics.
Similar content being viewed by others
References
Phipps, S., Dunavant, M., Garvie, P. A., Lensing, S., & Rai, S. N. (2002). Acute health-related quality of life in children undergoing stem cell transplant: I. Descriptive outcomes. Bone Marrow Transplantation, 29, 425–434.
Phipps, S., Dunavant, M., Lensing, S., & Rai, S. N. (2002). Acute health-related quality of life in children undergoing stem cell transplant: II. Medical and demographic determinants. Bone Marrow Transplantation, 29, 435–442.
Parsons, S. K., Phipps, S., Sung, L., Baker, K. S., Pulsipher, M. A., & Ness, K. K. (2012). NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Health-related quality of life, functional, and neurocognitive outcomes. Biology of Blood and Marrow Transplantation, 18, 162–171.
Parsons, S. K., Tighiouart, H., & Terrin, N. (2013). Assessment of health-related quality of life in pediatric hematopoietic stem cell transplant recipients: Progress, challenges and future directions. Expert Review of Pharmacoeconomics & Outcomes Research, 13, 217–225.
Cohen, M. Z., Ley, C., & Tarzian, A. J. (2001). Isolation in blood and marrow transplantation. Western Journal of Nursing Research, 23, 592–609.
Bonnetain, F., Paoletti, X., Collette, S., Doffoel, M., Bouche, O., Raoul, J. L., et al. (2008). Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: Results from two French clinical trials. Quality of Life Research, 17, 831–843.
Sadetsky, N., Hubbard, A., Carroll, P. R., & Satariano, W. (2009). Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: Data from CaPSURE (cancer of the prostate strategic urologic research endeavor) database. Quality of Life Research, 18, 1019–1027.
Tsai, W. L., Chien, C. Y., Huang, H. Y., Liao, K. C., & Fang, F. M. (2013). Prognostic value of quality of life measured after treatment on subsequent survival in patients with nasopharyngeal carcinoma. Quality of Life Research, 22, 715–723.
de Boer-van der Kolk, I. M., Sprangers, M. A., Prins, J. M., Smit, C., de Wolf, F., Nieuwkerk, P. T. (2010). Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: A study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort. Clin Infect Dis, 50, 255–263.
Olofson, J., Dellborg, C., Sullivan, M., Midgren, B., Caro, O., & Bergman, B. (2009). Qualify of life and palliation predict survival in patients with chronic alveolar hypoventilation and nocturnal ventilatory support. Quality of Life Research, 18, 273–280.
Rumsfeld, J. S., MaWhinney, S., McCarthy, M, Jr, Shroyer, A. L., VillaNueva, C. B., O’Brien, M., et al. (1999). Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. JAMA, 281, 1298–1303.
Khouli, H., Astua, A., Dombrowski, W., Ahmad, F., Homel, P., Shapiro, J., et al. (2011). Changes in health-related quality of life and factors predicting long-term outcomes in older adults admitted to intensive care units. Critical Care Medicine, 39, 731–737.
Felder-Puig, R., di Gallo, A., Waldenmair, M., Norden, P., Winter, A., Gadner, H., et al. (2006). Health-related quality of life of pediatric patients receiving allogeneic stem cell or bone marrow transplantation: Results of a longitudinal, multi-center study. Bone Marrow Transplantation, 38, 119–126.
Nuss, S. L., & Wilson, M. E. (2007). Health-related quality of life following hematopoietic stem cell transplant during childhood. Journal of Pediatric Oncology Nursing, 24, 106–115. doi:10.1177/1043454206296033.
Parsons, S. K., Shih, M. C., DuHamel, K. N., Ostroff, J., Mayer, D. K., Austin, J., et al. (2006). Maternal perspectives on children’s health-related quality of life during the first year after pediatric hematopoietic stem cell transplant. Journal of Pediatric Psychology, 31, 1100–1115.
Rodday, A. M., Terrin, N., & Parsons, S. K. (2013). Measuring global health-related quality of life in children undergoing hematopoietic stem cell transplant: A longitudinal study. Health and Quality of Life Outcomes, 11, 26.
Parsons, S. K., Shih, M. C., Ratichek, S., Recklitis, C. J., & Chang G for the Journeys to Recovery Study. (2006). Establishing the baseline in longitudinal evaluation of health-related quality of life (HRQL): The pediatric hematopoietic stem cell transplantation (HSCT) Example. presentation at the patient-reported outcomes assessment in cancer trials, National Cancer Institute, September 2006.
Parsons, S. K., Shih, M. C., Mayer, D. K., Barlow, S. E., Supran, S. E., Levy, S. L., et al. (2005). Preliminary psychometric evaluation of the Child Health Ratings Inventories (CHRIs) and Disease-Specific Impairment Inventory-HSCT (DSII-HSCT) in parents and children. Quality of Life Research, 14, 1613–1625.
Landgraf, J. M., & Abetz, L. (1994). The infant/toddler quality of life questionnaire: Conceptual framework, logic, content, and preliminary psychometric results. Final Report to Schering-Plough Laboratories and Health Technology Associates. Boston: New England Medical Center.
Raat, H., Landgraf, J. M., Oostenbrink, R., Moll, H. A., & Essink-Bot, M. L. (2007). Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample. Quality of Life Research, 16, 445–460.
Ibrahim, J. G., Chu, H., & Chen, L. M. (2010). Basic concepts and methods for joint models of longitudinal and survival data. Journal of Clinical Oncology, 28, 2796–2801.
Henderson, R., Diggle, P., & Dobson, A. (2000). Joint modelling of longitudinal measurements and event time data. Biostatistics, 1, 465–480.
Xu, J., & Zeger, S. (2001). Joint analysis of longitudinal data comprising repeated measures and times to events. Applied Statistics, 50, 375–387.
Tsiatis, A. A., & Davidian, M. (2004). Joint modeling of longitudinal and time-to-event data: An overview. Statistica Sinica, 14, 809–834.
Rizopoulos, D. (2010). JM: An R package for the joint modelling of longitudinal and time-to-event data. Journal of Statistical Software, 35(9), 1–33.
Rizopoulos, D. (2012). Joint models for longitudinal and time-to-event data: With applications in R (1st ed.). New York: CRC Press.
Klein Entink, R. H., Fox, J. P., & van den Hout, A. (2011). A mixture model for the joint analysis of latent developmental trajectories and survival. Statistics in Medicine, 30, 2310–2325.
Acknowledgments
This work was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), Grant Number UL1 TR000073 through Tufts Clinical and Translational Science Institute (CTSI), and the NIH National Cancer Institute Grant R21 CA152628 through the Institute for Clinical Research and Health Policy Studies (ICRHPS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
Model building for the longitudinal submodels
Appendix Table 3 shows which covariates were considered for each longitudinal submodel. Variables that were associated with a longitudinal outcome at p < 0.10 were tested in multivariable models using backward elimination with p < 0.05.
The joint model
The notation is defined in Appendix Table 4. The longitudinal submodel for the ith individual at time t is
where in the case of emotional functioning, for example, \(\eta_{i} \left( t \right)\)is the sum of a natural cubic spline (ns) with fixed effects coefficients and a ns with random effects coefficients. The random effects have multivariate normal distribution with mean zero. The errors are independent and normally distributed with mean zero and are also independent of the random effects.
The survival submodel for the ith individual is defined by the cause-specific hazards for TRM
and disease-related mortality
The log baseline hazard is approximated by b-splines.
The joint distribution of HRQL (one domain at a time), TRM, and disease-related mortality was modeled as
The joint model assumes that observed HRQL and mortality are conditionally independent, given the latent HRQL.
R Code for emotional functioning joint model
-
#### Cox PH Competing Risk Model ####
-
#Data for Cox PH (before competing risk format)
-
data_surv
id | event | eventtime | childfemale | hscttype |
---|---|---|---|---|
141 | 1 | 76 | 1 | 1 |
143 | 0 | 447 | 0 | 0 |
145 | 0 | 360 | 0 | 0 |
148 | 0 | 374 | 1 | 1 |
152 | 0 | 378 | 0 | 0 |
154 | 1 | 12 | 1 | 0 |
155 | 0 | 388 | 0 | 0 |
156 | 0 | 466 | 1 | 1 |
158 | 0 | 465 | 1 | 0 |
160 | 0 | 399 | 0 | 0 |
: |
-
#create competing risk dataset
-
data_surv_cr <-crLong(data_surv, “event”,”0”)
-
data_surv_cr
id | event | eventtime | childfemale | hscttype | strata | status2 | |
---|---|---|---|---|---|---|---|
141 | 141 | 1 | 76 | 1 | 1 | 1 | 1 |
141.1 | 141 | 1 | 76 | 1 | 1 | 2 | 0 |
143 | 143 | 0 | 447 | 0 | 0 | 1 | 0 |
143.1 | 143 | 0 | 447 | 0 | 0 | 2 | 0 |
145 | 145 | 0 | 360 | 0 | 0 | 1 | 0 |
145.1 | 145 | 0 | 360 | 0 | 0 | 2 | 0 |
148 | 148 | 0 | 374 | 1 | 1 | 1 | 0 |
148.1 | 148 | 0 | 374 | 1 | 1 | 2 | 0 |
152 | 152 | 0 | 378 | 0 | 0 | 1 | 0 |
152.1 | 152 | 0 | 378 | 0 | 0 | 2 | 0 |
: |
-
#Fit Cox PH competing risk model
-
fitCoxef_cr <-coxph(Surv(eventtime, status2) ~ (childfemale + hscttype)*strata + strata(strata), data = data_surv_cr, x = T)
-
#### Code for LME Model ####
-
#Data for LME model
-
data_long
id | time | childEF |
---|---|---|
141 | −7 | 0.000 |
141 | 42 | 5.000 |
143 | −25 | 5.714 |
143 | 107 | 8.571 |
143 | 155 | 8.929 |
143 | 360 | 8.929 |
143 | 416 | 8.571 |
145 | −18 | 6.429 |
145 | 45 | 4.643 |
145 | 88 | 5.714 |
: |
-
#Fit LME model
-
fitLMEef <-lme(childEF ~ ns(time, df = 4),
-
random = list(id = pdDiag(form = ~ ns(time, df = 4))),
-
na.action = na.omit, data = data_long)
-
#### Code for JM Model ####
-
fitJMef <-jointModel(fitLMEef, fitCoxef_cr, timeVar = ”time”, method = ”spline-PH-aGH”, interFact = list(value = ~strata, data = data_surv_cr), CompRisk = T)
Rights and permissions
About this article
Cite this article
Terrin, N., Rodday, A.M. & Parsons, S.K. Joint models for predicting transplant-related mortality from quality of life data. Qual Life Res 24, 31–39 (2015). https://doi.org/10.1007/s11136-013-0550-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-013-0550-2